Amaranth Medical Announces Investment from Boston Scientific
January 14, 2014 at 09:16 AM EST
Amaranth Medical today announced the closing of an equity investment by Boston Scientific Corporation (NYSE: BSX ). The additional investment capital will be used to advance the clinical development of the Amaranth FORTITUDE™ drug eluting bioresorbable scaffold in a planned international clinical study and subsequent application for CE Mark. In addition, the funding will support